May 17, 2023
A derivative lawsuit settlement that produced a package of Geron Corp. corporate governance reforms and a $1.35 million attorney fee cleared the Delaware Chancery Court on Wednesday, capping years of direct and derivative litigation over company failures to disclose negative drug trial results.